Neurologist and Nerve Pathology Lab Director @MayoClinic. Vice-Chair of Education @PNSociety1. Check my highlights to learn more about peripheral neuropathy.
Rochester, MN
Joined June 2019
- Tweets4.2K
- Following950
- Followers5.7K
- Likes11.9K
Pinned Tweet
I am excited to share my review article, “Amyloid Neuropathies,” published in @ContinuumAAN. My journey caring for patients with amyloid neuropathies began 14 years ago at the Brazilian Amyloidosis Referral Center at my alma mater, @ufrj. Since moving to @MayoClinic, I’ve continued my clinical work and research in amyloidosis, which has given me a unique perspective on patient care across two very different settings. I’ve aimed to simplify this complex topic, including many clinical pearls and a diagnostic flow chart highlighting key red flags.
I’m also proud to share that @LyellJ selected this article as one of the editor’s picks, making it freely available for the next three months. Don’t miss out—download it now! 😊
continuum.aan.com/doi/pdf/10…
Lastly, I want to say it's such an honor to write for @ContinuumAAN, which was the most important neurology journal throughout my (long) neurology training journey. The opportunity to give back through this review was very meaningful to me.
I hope you all enjoy it!
Marcus Pinto, MD, MS retweeted
📢 Applications open for the 2027 Muscle Disorders Fellowship at @MayoClinic!
Advanced training in muscle diseases for neurology residents, #neuromuscular fellows & eligible IMGs (USMLE + ECFMG).
Learn more: college.mayo.edu/academics/r…
Marcus Pinto, MD, MS retweeted
After both ECTRIMS2026 and American Neurological Association, I was reflecting on how #autoantibody-mediated neurological diseases are such precise clinical and biological entities. Few other diseases carry such homogeneity.
In 2023, @EoinFlanagan14 @adrianbudhram1 and I proposed it would be better to split, rather than lump. We suggested that the antibody itself - especially when highly specific - should be the gateway to diagnosis.
The fundamental demographics, clinical features and biological characteristics differ so markedly (see table) based on the antigen
It’s a key theme across our two main 2026 reviews and calls for a rethink re nomenclature of these conditions.
thelancet.com/journals/lance…
@TheLancet
academic.oup.com/brain/artic…
@Brain1878
The autoantigen defines so so so much! It must be put at the center.
Marcus Pinto, MD, MS retweeted
Join us @ IDWeek ! Thankful to all the hardworking residents & fellows ..
🤖 Made with AI
Marcus Pinto, MD, MS retweeted
Not a one-way street: diabetic polyneuropathy can regress even in long-standing type1 diabetes
On Neurodiab website every Monday a signaling of articles on #diabeticneuropathy
The 249th Publication News is by Aleksandra Araszkiewicz (neurodiab.eu/publication-new…)
Marcus Pinto, MD, MS retweeted
Long-awaited results of CREST-H are out. @MayoClinicNeuro Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment jamanetwork.com/journals/jam…
Marcus Pinto, MD, MS retweeted
From the brain to peripheral nerves?
A @NatureComms study shows semaglutide reduces neuroinflammation in mice. Could similar anti-inflammatory effects also help protect against diabetic neuropathy?
Worth reading 👇🏻
nature.com/articles/s41467-0…
Marcus Pinto, MD, MS retweeted
Neurology® now has a Journal Impact Factor of 10.8 per Clarivate's 2025 Journal Citation Reports. Thank you to the authors, reviewers, and editors whose work makes this possible. Read the latest: hubs.la/Q04Bmtq80
Marcus Pinto, MD, MS retweeted
Key Point 3 from the first Editor's Pick "Amyloid Neuropathies" by Marcus V. Pinto, MD, MS, from the October #PeripheralNerve and Motor Neuron Disorders issue, which is available to all at hubs.la/Q04z2LCM0.
#MedEd #NeuroTwitter
Marcus Pinto, MD, MS retweeted
Skeletal muscle microvascular dysfunction in diabetic peripheral neuropathy
On Neurodiab website every Monday a signaling of articles on #diabeticneuropathy
The 248th Publication News is by Anders Stouge (neurodiab.eu/publication-new…)
Marcus Pinto, MD, MS retweeted
I am excited to share my review article, “Amyloid Neuropathies,” published in @ContinuumAAN. My journey caring for patients with amyloid neuropathies began 14 years ago at the Brazilian Amyloidosis Referral Center at my alma mater, @ufrj. Since moving to @MayoClinic, I’ve continued my clinical work and research in amyloidosis, which has given me a unique perspective on patient care across two very different settings. I’ve aimed to simplify this complex topic, including many clinical pearls and a diagnostic flow chart highlighting key red flags.
I’m also proud to share that @LyellJ selected this article as one of the editor’s picks, making it freely available for the next three months. Don’t miss out—download it now! 😊
continuum.aan.com/doi/pdf/10…
Lastly, I want to say it's such an honor to write for @ContinuumAAN, which was the most important neurology journal throughout my (long) neurology training journey. The opportunity to give back through this review was very meaningful to me.
I hope you all enjoy it!
Marcus Pinto, MD, MS retweeted
Key Point 4 from the first Editor's Pick "Amyloid Neuropathies" by Marcus V. Pinto, MD, MS, from the October #PeripheralNerve and Motor Neuron Disorders issue, which is available to all at hubs.la/Q04z2M4C0.
#MedEd #NeurologyEd
Marcus Pinto, MD, MS retweeted
Why does diabetic peripheral neuropathy hurt in some people but notin others?
On Neurodiab website every Monday a signaling of articles on #diabeticneuropathy
The 247th Publication News is by Astrid Wiggers (neurodiab.eu/publication-new…)
Marcus Pinto, MD, MS retweeted
Key Point 2 from the first Editor's Pick "Amyloid Neuropathies" by Marcus V. Pinto, MD, MS, from the October #PeripheralNerve and Motor Neuron Disorders issue, which is available to all at hubs.la/Q04z2KNZ0.
#MedEd #NeuroTwitter
Marcus Pinto, MD, MS retweeted
More on this at the @AANmember Fall meeting PNS update, including clinical pointers like this from @MarcusVPinto!
Key Point 1 from the first Editor's Pick "Amyloid Neuropathies" by Marcus V. Pinto, MD, MS, from the October #PeripheralNerve and Motor Neuron Disorders issue, which is available to all at hubs.la/Q04z2Lf20.
#MedEd #NeuroTwitter
Marcus Pinto, MD, MS retweeted
Key Point 1 from the first Editor's Pick "Amyloid Neuropathies" by Marcus V. Pinto, MD, MS, from the October #PeripheralNerve and Motor Neuron Disorders issue, which is available to all at hubs.la/Q04z2Lf20.
#MedEd #NeuroTwitter
Marcus Pinto, MD, MS retweeted
A big thank you to everyone who joined the #NEUROdiab Symposium at #EASD2026 in Milan. Excellent science, lively discussion, and great participation onsite and online.
🎥 Replay available here: virtualcongress.easd.org/pag…
Marcus Pinto, MD, MS retweeted
The October #PeripheralNerve and Motor Neuron Disorders issue, guest edited by Dr. Noah Kolb, is now available at hubs.la/Q04z2PKs0!
@LyellJ @AANmember #NeuroX #MedEd #Neurology
Marcus Pinto, MD, MS retweeted
The latest issue of Continuum, on Peripheral Nerve and Motor Neuron Disease, is online and shipping!
Great issue, everything you need to know about PN and MND, guest edited by Dr. Noah Kolb.
In my opinion, worth it just for this wonderful cover art by @grundini
Marcus Pinto, MD, MS retweeted
Come to my peripheral nerve update on Saturday morning!
See you in Vegas 😎
Don't miss the outstanding programming at the 2026 AAN Fall Conference.
Get the latest neurology updates, practical education, and CME opportunities. Join us October 9-11 in Las Vegas or online.
The advance registration deadline is today: hubs.la/Q04xgXsv0
